-
1 Comment
Hualan Biological Engineering Inc is currently in a long term downtrend where the price is trading 17.5% below its 200 day moving average.
From a valuation standpoint, the stock is 51.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 14.6.
Hualan Biological Engineering Inc's total revenue rose by 83.7% to $2B since the same quarter in the previous year.
Its net income has increased by 103.0% to $649M since the same quarter in the previous year.
Finally, its free cash flow grew by 18.4% to $616M since the same quarter in the previous year.
Based on the above factors, Hualan Biological Engineering Inc gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000001JN8 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 30B |
|---|---|
| Beta | 0.65 |
| Target Price | 18.7 |
| Dividend Yield | 1.7% |
| PE Ratio | 27.73 |
Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes blood products, vaccines, and recombinant proteins in China and internationally. The company offers blood products under the Hualan brand comprising human albumin, intravenous human immunoglobulin, human immunoglobulin, tetanus human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, human prothrombin complex, human coagulation factor VIII, human fibrinogen, freeze-dried human fibrin glue for surgery, and human fibrin adhesives. It also provides vaccines consisting of quadrivalent and split influenza virus vaccines, influenza A (H1N1) split vaccines, ACYW135 group meningococcal polysaccharide vaccines, recombinant hepatitis B vaccines, group A and C meningococcal polysaccharide vaccines, freeze-dried human rabies vaccines, adsorbed tetanus vaccines, and multiple vaccine products; and biological products. In addition, the company is involved in plasma collection; poultry breeding for research and development; engineering technology research and experimental development; inspection and testing; biotechnology development; and medical services. Hualan Biological Engineering Inc. was founded in 1992 and is headquartered in Xinxiang City, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002007.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
